These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 10811889)

  • 1. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.
    Trang P; Lee M; Nepomuceno E; Kim J; Zhu H; Liu F
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5812-7. PubMed ID: 10811889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1.
    Trang P; Kilani A; Kim J; Liu F
    J Mol Biol; 2000 Aug; 301(4):817-26. PubMed ID: 10966788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells.
    Zou H; Lee J; Umamoto S; Kilani AF; Kim J; Trang P; Zhou T; Liu F
    J Biol Chem; 2003 Sep; 278(39):37265-74. PubMed ID: 12867424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNase P ribozymes for the studies and treatment of human cytomegalovirus infections.
    Trang P; Kilani A; Lee J; Hsu A; Liou K; Kim J; Nassi A; Kim K; Liu F
    J Clin Virol; 2002 Aug; 25 Suppl 2():S63-74. PubMed ID: 12361758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth.
    Trang P; Kim K; Zhu J; Liu F
    J Mol Biol; 2003 May; 328(5):1123-35. PubMed ID: 12729746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis C virus by an M1GS ribozyme derived from the catalytic RNA subunit of Escherichia coli RNase P.
    Mao X; Li X; Mao X; Huang Z; Zhang C; Zhang W; Wu J; Li G
    Virol J; 2014 May; 11():86. PubMed ID: 24885776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus late protein encoded by ie2: a trans-activator as well as a repressor of gene expression.
    Jenkins DE; Martens CL; Mocarski ES
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2337-48. PubMed ID: 8077932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular expression of engineered RNase P ribozymes effectively blocks gene expression and replication of human cytomegalovirus.
    Kim K; Umamoto S; Trang P; Hai R; Liu F
    RNA; 2004 Mar; 10(3):438-47. PubMed ID: 14970389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus].
    Zhang W; Li X; Luo G; Huang Z; Liu Y
    Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):875-81. PubMed ID: 24341280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins.
    Kim K; Trang P; Umamoto S; Hai R; Liu F
    Nucleic Acids Res; 2004; 32(11):3427-34. PubMed ID: 15220469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant.
    Sun X; Chen W; He L; Sheng J; Liu Y; Vu GP; Yang Z; Li W; Trang P; Wang Y; Hai R; Zhu H; Lu S; Liu F
    PLoS One; 2017; 12(10):e0186791. PubMed ID: 29059242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic M1GS RNA as an antiviral agent in animals.
    Bai Y; Rider PJ; Liu F
    Methods Mol Biol; 2010; 629():339-53. PubMed ID: 20387160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced levels of IE2 gene expression and shutdown of early and late viral genes during latent infection of the glioblastoma cell line U138-MG with selectable recombinants of human cytomegalovirus.
    Wolff D; Sinzger C; Drescher P; Jahn G; Plachter B
    Virology; 1994 Oct; 204(1):101-13. PubMed ID: 8091645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNase P ribozyme as an antiviral agent against human cytomegalovirus.
    Trang P; Liu F
    Methods Mol Biol; 2004; 252():437-50. PubMed ID: 15017069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins.
    Malone CL; Vesole DH; Stinski MF
    J Virol; 1990 Apr; 64(4):1498-506. PubMed ID: 2157038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable expression of functional human cytomegalovirus immediate-early proteins IE1 and IE2 in HeLa cells.
    Yuo CY; Wu GJ; Huang ES; Wu FY; Wu CW
    Intervirology; 1992; 34(2):94-104. PubMed ID: 1338063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5' Untranslated Region of the Major Immediate Early mRNA Is Necessary for Efficient Human Cytomegalovirus Replication.
    Arend KC; Lenarcic EM; Moorman NJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression.
    Meier JL; Pruessner JA
    J Virol; 2000 Feb; 74(4):1602-13. PubMed ID: 10644329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function.
    Adamson CS; Nevels MM
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31963209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.